logo

For the Inventor, By the Inventor

Gales Ferry, CT, United States of America

Paul D Weeks

USPTO Granted Patents = 18

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 33(Granted Patents)


Company Filing History:

goldMedal18 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1978-1985

Loading Chart...
18 patents (USPTO):Explore Patents
1. 4530792 - Process and intermediates for preparation of (1985-07-23),
2. 4483982 - Processes for preparing piroxicam and intermediates leading thereto (1984-11-20),
3. 4468351 - Process for debromination of dibromopenicillanic acid and derivatives (1984-08-28),
4. 4451661 - Preparation of gamma-pyrone intermediates (1984-05-29),
5. 4443621 - p-Nitrophenyl 3-bromo-2,2-diethoxy-propionate and synthetic utility (1984-04-17),
6. 4435584 - Preparation of gamma-pyrones (1984-03-06),
7. 4390709 - Preparation of gamma-pyrones (1983-06-28),
8. 4387235 - Intermediates for the preparation of gamma-pyrones (1983-06-07),
9. 4376204 - 3-Hydroxy 2-methyl benzisothiazolines as intermediates in production of (1983-03-08),
10. 4368331 - 3,4-Dihalo-tetrahydrophyran-5-one useful as intermediates for the (1983-01-11),
11. 4342697 - Preparation of gamma-pyrones (1982-08-03),
12. 4323506 - Preparation of gamma-pyrones (1982-04-06),
13. 4289704 - Preparation of gamma-pyrones (1981-09-15),
14. 4191693 - Preparation of gamma-pyrones from 3-substituted furans (1980-03-04),
15. 4173572 - Preparation of gamma-pyrones from 3-substituted furans (1979-11-06),

Title: Innovations by Paul D. Weeks: Pioneering Pharmaceutical Patents

Introduction

Paul D. Weeks, an accomplished inventor based in Gales Ferry, Connecticut, has made significant contributions to the pharmaceutical industry with 18 patents to his name. His work focuses primarily on innovative processes for the preparation of crucial compounds, showcasing his expertise and commitment to advancing medical science.

Latest Patents

Among his latest inventions, Paul D. Weeks has developed a groundbreaking process for the preparation of 1,1-dioxopenicillanoyloxymethyl 6-beta-aminopenicillanate. This intricate process involves reacting specific compounds under anhydrous conditions with a halogenating agent and includes subsequent steps using primary alcohols and hydrolysis to yield the desired product.

Furthermore, he has also pioneered processes for preparing piroxicam, an anti-inflammatory agent. These innovative processes encompass the reactions of N-methylsaccharin with (N-2-pyridyl) haloacetamides and alkyl haloacetates, leading to the formation of piroxicam and intermediates crucial for its production. His inventions also explore novel reactions involving alkyl 2-(2-methyl-3-hydroxy-2,3-dihydro-1,2-benzisosulfonazol-3-yl)-2-haloacetate, further enhancing the pathways to obtain effective pharmaceutical agents.

Career Highlights

Paul D. Weeks is currently affiliated with Pfizer Corporation, a leading global biopharmaceutical company known for its innovative drug development. His tenure at Pfizer highlights his essential role in the continuous quest to discover and develop new therapeutic solutions.

Collaborations

Working alongside notable colleagues such as Thomas M. Brennan and Daniel P. Brannegan, Paul D. Weeks has fostered collaborative efforts that enhance the inventive process within the context of pharmaceutical innovation. Their combined knowledge and expertise contribute to the success of the projects they undertake.

Conclusion

With his extensive patent portfolio and impactful innovations, Paul D. Weeks epitomizes the spirit of invention that drives advancements in the pharmaceutical industry. His processes not only demonstrate technical ingenuity but also hold the potential to improve health outcomes for countless individuals, solidifying his legacy as a forward-thinking innovator in the realm of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…